Issue 2/2023
Content (10 Articles)
What Role for Long-Acting Injectable Antipsychotics in Managing Schizophrenia Spectrum Disorders in Children and Adolescents? A Systematic Review
Inmaculada Baeza, Adriana Fortea, Daniel Ilzarbe, Gisela Sugranyes
Treatment Options for Juvenile Pityriasis Rubra Pilaris
Jana Guenther, Danielle Novack, Sonia Kamath, Scott Worswick
Treatment Options in Pediatric Behçet’s Disease
Teresa Giani, Angela Flavia Luppino, Giovanna Ferrara
Pharmacological Management of Atypical Hemolytic Uremic Syndrome in Pediatric Patients: Current and Future
Evgenia Gurevich, Daniel Landau
Adverse Drug Reactions in Children: Comparison of Reports Collected in a Pharmacovigilance Project Versus Spontaneously Collected ADR Reports
Sarah Leitzen, Diana Dubrall, Irmgard Toni, Julia Stingl, Patrick Christ, Ursula Köberle, Matthias Schmid, Antje Neubert, Bernhardt Sachs
Characterization of Cardiac Function by Echocardiographic Global Longitudinal Strain in a Cohort of Children with Neurofibromatosis Type 1 Treated with Selumetinib
Thomas Caiffa, Antimo Tessitore, Andrea Magnolato, Matilde Petz, Marco Bobbo, Daniela Chicco, Biancamaria D’Agata Mottolese, Aldostefano Porcari, Egidio Barbi, Gianfranco Sinagra, Irene Bruno
Letermovir for Prophylaxis and Pre-emptive Therapy of Cytomegalovirus Infection in Paediatric Allogeneic Haematopoietic Cell Transplant Patients
Katharina F. Körholz, Miriam A. Füller, Marc Hennies, Malcolm Holterhus, Susanne Hagedorn, Martina Ahlmann, Heike Thorer, Birgit Burkhardt, Andreas H. Groll
Diagnosis of Serious Conditions Delayed in Association with Ondansetron Treatment for Vomiting in the Pediatric Emergency Department
Gili Palnizky Soffer, Zeev Schnapp, Dana Miroluz, Ayelet Rimon
Correction to: Multidisciplinary Clinical Care in the Management of Patients Receiving Anti‑GD2 Immunotherapy for High‑Risk Neuroblastoma
Jennifer Cabral, Erica I. Fernandez, Bonnie Toy, Rita Secola